Mode
Text Size
Log in / Sign up
Phase 4 N=121 Randomized Quadruple-blind Prevention

Aprepitant Versus Ondansetron in Preoperative Triple-therapy Treatment of Nausea and Vomiting

Postoperative Nausea and Vomiting (PONV) · Nausea

Enrolled (actual)
121
Serious AEs
4.1%
Results posted
Dec 2013
Primary outcome: Primary: Proportion of Patients With a Complete Response/Complete Control During the First 24 Hours After Neurological Surgery Under General Anesthesia — 38; 41; 30; 30 participants

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Aprepitant (Drug); Ondansetron (Drug); Promethazine (Drug); Dexamethasone (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Sergio Bergese
Primary completion
Dec 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Proportion of Patients With a Complete Response/Complete Control During the First 24 Hours After Neurological Surgery Under General Anesthesia
38; 41; 30; 30
SECONDARY
Post Operative Nausea and Vomiting (PONV) Scores on a Verbal Response Scale
1; 1; 1.5; 1.5

Summary

This study is being done to determine the efficacies of two preventative drug combinations for postoperative nausea and vomiting in patients undergoing neurosurgery. The aim of this study is to compare the efficacy of using aprepitant instead of ondansetron in combination with dexamethasone and promethazine for post-operative nausea and vomiting prophylaxis. By completing this comparison study investigators will determine the most efficacious drug combination which will allow us to enhance the overall comfort and satisfaction of neurosurgical patients in the immediate postoperative period.

Eligibility Criteria

Inclusion Criteria

  • Adult patients
  • 18 to 85 years of age
  • Scheduled for neurosurgery requiring opening of the cranium and dura at Ohio State University Medical Center and who consent in writing to participate in this study are eligible.

Exclusion Criteria

  • Patients will be excluded from this study if they are
  • prisoners
  • pregnant women
  • mentally ill
  • under the age of 18 or over the age of 85
  • American Society of Anesthesiologist (ASA) classification V
  • alcohol or drug abusers
  • have a cerebral perfusion pressure (CPP) greater than 150 mmHg or less than 50 mmHg.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01474915). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search